No Data
BioVie Receives Notice Of Allowance For U.S. Patent Application Covering Novel Liquid Formulation Of Terlipressin
Express News | BioVie Receives Notice of Allowance for United States Patent Application Covering Novel Liquid Formulation of Terlipressin
BioVie | 10-K: FY2024 Annual Report
12 Health Care Stocks Moving In Thursday's After-Market Session
BioVie Bolsters Capital With Public Offering and Warrant Adjustment
Top Midday Decliners